News

Ethereum is once again mirroring a previous bullish pattern, rekindling optimism for a rally. After weeks of sideways trading ...
There are also successful implementations of architectural blueprints for generative AI solutions that guarantee data privacy and compliant data processing under HIPAA and GDPR. Yet, as ...
Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced non ...